image
Figure 3: Most frequent adverse drug reactions (ADRs) during intraseasonal up-dosing (≥ 1% of patients, total patients) for patients who started subcutaneous immunotherapy (SCIT) up to the peak of the grass pollen season (‘up to peak GPS’) or after the peak of the grass pollen season (‘after peak GPS’). ADRs were coded according to the Medical Dictionary for Regulatory Activities (MedDRA).
Goto home»